225 related articles for article (PubMed ID: 27142799)
1. [Focal therapy of prostate cancer in Germany].
Apfelbeck M; Herlemann A; Stief CG; Gratzke C
Urologe A; 2016 May; 55(5):584-92. PubMed ID: 27142799
[TBL] [Abstract][Full Text] [Related]
2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
3. Low-risk Prostate Cancer: Identification, Management, and Outcomes.
Moschini M; Carroll PR; Eggener SE; Epstein JI; Graefen M; Montironi R; Parker C
Eur Urol; 2017 Aug; 72(2):238-249. PubMed ID: 28318726
[TBL] [Abstract][Full Text] [Related]
4. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
5. [Focal therapy for prostate cancer in Germany - 2014 status].
Roosen A; Ganzer R; Hadaschik B; Köllermann J; Blana A; Henkel T; Liehr AB; Baumunk D; Machtens S; Salomon G; Sentker L; Witsch U; Köhrmann KU; Schostak M;
Urologe A; 2014 Jul; 53(7):1040-5. PubMed ID: 24941932
[TBL] [Abstract][Full Text] [Related]
6. Management of early-stage prostate cancer.
Shore N
Am J Manag Care; 2014 Dec; 20(12 Suppl):S260-72. PubMed ID: 25734965
[TBL] [Abstract][Full Text] [Related]
7. [Active surveillance for low-risk prostate cancer].
Herlemann A; Stief CG
Urologe A; 2016 Feb; 55(2):269-81. PubMed ID: 26831055
[TBL] [Abstract][Full Text] [Related]
8. [Active surveillance of low risk prostate cancer].
Lellig K; Beyer B; Graefen M; Zaak D; Stief C
Urologe A; 2014 Jul; 53(7):1031-9. PubMed ID: 24957523
[TBL] [Abstract][Full Text] [Related]
9. [Novelties in diagnostics and treatment of prostate cancer].
Riesz P; Nyírádi P
Orv Hetil; 2016 Mar; 157(11):410-4. PubMed ID: 26947089
[TBL] [Abstract][Full Text] [Related]
10. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
[TBL] [Abstract][Full Text] [Related]
12. Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort.
Seiler D; Randazzo M; Klotz L; Grobholz R; Baumgartner M; Isbarn H; Recker F; Kwiatkowski M
BJU Int; 2012 Jul; 110(2):195-200. PubMed ID: 22093744
[TBL] [Abstract][Full Text] [Related]
13. Conventional treatments of localized prostate cancer.
Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
[TBL] [Abstract][Full Text] [Related]
14. Localised prostate cancer - current treatment options.
Duchesne G
Aust Fam Physician; 2011 Oct; 40(10):768-71. PubMed ID: 22003477
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance for prostate cancer: past, present and future.
Singer EA; Kaushal A; Turkbey B; Couvillon A; Pinto PA; Parnes HL
Curr Opin Oncol; 2012 May; 24(3):243-50. PubMed ID: 22450149
[TBL] [Abstract][Full Text] [Related]
16. Value of Endorectal MRI in Romanian Men for High Risk of Prostate Cancer: MRI Findings Compared with Saturation Biopsy.
Lebovici A; Sfrangeu SA; Caraiani C; Lucan C; Suciu M; Elec F; Iacob G; Buruian M;
Chirurgia (Bucur); 2015; 110(3):262-7. PubMed ID: 26158736
[TBL] [Abstract][Full Text] [Related]
17. Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?
Tay KJ; Mendez M; Moul JW; Polascik TJ
Curr Opin Urol; 2015 May; 25(3):185-90. PubMed ID: 25768694
[TBL] [Abstract][Full Text] [Related]
18. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
19. [Nerve sparing radical retropubic prostatectomy and lymph node excision in prostate carcinoma].
Heidenreich A; Hammerer P
Aktuelle Urol; 2013 May; 44(3):223-42. PubMed ID: 23716024
[No Abstract] [Full Text] [Related]
20. Evolution from active surveillance to focal therapy in the management of prostate cancer.
Lindner U; Lawrentschuk N; Schatloff O; Trachtenberg J; Lindner A
Future Oncol; 2011 Jun; 7(6):775-87. PubMed ID: 21675840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
